No actionable bearish signal from this cluster. CEO selling at ~0.006% market cap is routine diversification. Monitor the next quarterly filing (Form 4/10-Q) for any acceleration or broadening of C-suite sales volume, but no near-term catalyst is implied. The broad equity grants on June 2 suggest normal compensation cycles, not distress.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 9 $212.88entry
- T+1 · 5mo ago −2.25%α −0.67% · $208.10
- T+5 · 5mo ago −3.26%α −5.68% · $205.93
- T+20 · 4mo ago +1.18%α −0.27% · $215.39
- T+60 · 3mo ago +8.08%α +4.27% · $230.08
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Daniel Carestio and Director Richard Breeden sold a combined $966K in open-market STE shares over a 5-day window (May 28–June 4), while a separate cluster filing shows Carestio also sold an additional $291K on June 5. Tax-withholding and equity-grant transactions by multiple executives (Burton, Fraser, Kohler, Zangerle, Madsen, Tamaro, Boulud) are non-cash events with no economic signal. The open-market sales total ~0.005% of STE's $20.7B market cap, well below the 0.1% threshold for materiality, and CEO selling is not accompanied by broad C-suite or director selling (only 2 insiders). The sales are likely routine diversification rather than an informed negative signal.
Key Financial Metrics
Key Facts
- CEO Daniel Carestio sold $947K open-market (June 4-5, $212-$215 range), plus $291K on June 5 per separate filing
- Director Richard Breeden sold $310K open-market on June 2 at $209.51
- Total open-market cash-out: ~$1.26M across 3 insiders; ~0.006% of $20.7B market cap
- Multiple executives (CFO, SVP, etc.) had non-cash tax-withholding and equity-grant transactions, no economic signal
Financial Impact
Total open-market sales of ~$1.26M against $20.7B market cap; no material economic impact or change in ownership structure
Risk Factors
- CEO continued selling in subsequent periods could signal waning conviction; watch next 10-Q for revenue/earnings trajectory
- Sector headwinds in surgical supplies/margin pressure could emerge without insider trading as a leading indicator
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-STE-1780950733972 |
Track record
22 reports on STE
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +17.96% at T+20 after the Oct 13, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 4/10 Entry $259.32 Now $261.91 +1.00% settles Nov 25
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $261.91 Now $261.91 +0.00% settles Nov 23
- Nov 12, 20265d ago Insider Cluster Neutral 2/10 Entry $264.32 Now $261.91 −0.91% settles Nov 20
- Nov 12, 20265d ago 8-K Neutral 4/10 Entry $264.32 Now $261.91 −0.91% settles Nov 20
- Nov 12, 20265d ago 144 Neutral 2/10 Entry $253.44 Now $261.91 +3.34% settles Nov 19
- Nov 10, 20267d ago 144 Neutral 2/10 Entry $256.27 Now $261.91 +2.20% settles Nov 18
- Nov 4, 202613d ago 8-K Neutral 4/10 Entry $254.12 to $253.44 Now $261.91 +3.07% ▼ −0.27% −3.56% vs SPY
- Nov 4, 202613d ago 8-K Bullish 6/10 No price data
- Nov 4, 202613d ago Press Release Bullish 6/10 Entry $254.12 to $253.44 Now $261.91 +3.07% ▼ −0.27% −3.56% vs SPY
- Oct 28, 202620d ago Press Release Neutral 2/10 Entry $232.14 to $254.12 Now $261.91 +12.82% ▲ +9.47% +14.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers